Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Dash

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Indian Journal of Medical Microbiology|July 28, 2007
Persistent strongyloidiasis in a case of common variable immunodeficiencyL Dash, A Koticha, P R Mehta, et al.
European Journal of Immunology|March 1, 1995
CD40 ligand is functionally expressed on human eosinophilsJ F Gauchat, S Henchoz, D Fattah, et al.
FEBS Letters|November 30, 2000
Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)A Kaptein, M Jansen, G Dilaver, et al.
Cytokine|August 18, 2001
Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificityI J Uings, P Balasubramanian, P G McLoughlin, et al.
The Journal of Hospital Infection|February 6, 2022
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre studyM Biswal, P Gupta, R Kanaujia, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Indian Journal of Medical Microbiology|July 28, 2007
Persistent strongyloidiasis in a case of common variable immunodeficiencyL Dash, A Koticha, P R Mehta, et al.
European Journal of Immunology|March 1, 1995
CD40 ligand is functionally expressed on human eosinophilsJ F Gauchat, S Henchoz, D Fattah, et al.
FEBS Letters|November 30, 2000
Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)A Kaptein, M Jansen, G Dilaver, et al.
Cytokine|August 18, 2001
Modified peptide antagonists of interleukin 5 exhibit extended in vivo persistence but restricted species specificityI J Uings, P Balasubramanian, P G McLoughlin, et al.
The Journal of Hospital Infection|February 6, 2022
Evaluation of hospital environment for presence of Mucorales during COVID-19-associated mucormycosis outbreak in India - a multi-centre studyM Biswal, P Gupta, R Kanaujia, et al.
Pageof 1